Shaking up protein times 6
ORLANDO, Fla. —BSN last month showcased its line of ready-to-drink protein supplements at the ECRM Vitamin, Diet & Sports Nutrition meeting here. The company’s RTD protein supplements already are best-sellers at specialty shop GNC and military retailer AAFES.
The new-to-mass RTD protein shake, called Syntha-6, features six proteins—including milk, whey and soy—that each are metabolized by the body at different rates, allowing for a more gradual supplementation of protein.
Sports enthusiasts and avid dieters may be credited with driving sales of protein supplements higher last year by some 22%; for the 52 weeks ended Dec. 26, 2009, sales of protein supplements reached $148.3 million across food, drug and mass (including Walmart), according to Nielsen Group data.
For 2010, BSN is planning $3.2 million in advertising.
NCPA praises DME accreditation exemption provision
ALEXANDRIA, Va. A move by members of the Senate to exempt pharmacists from accreditation requirements for selling durable medical equipment has drawn praise from an organization representing independent pharmacies.
The National Community Pharmacists Association praised a move by Sens. Max Baucus, D-Mont., Sam Brownback, R-Kan., Chuck Grassley, R-Iowa, and Jon Tester, D-Mont., to permanently exempt pharmacists from the requirements. Many state-regulated healthcare professionals already are exempt, and the NCPA has long pushed for pharmacists to be exempt as well.
“Pharmacists are already state licensed, and 17 other state-regulated healthcare providers have been exempted from this regulation,” NCPA EVP and CEO Bruce Roberts said in a statement. “It’s simply unreasonable to ask community pharmacist, many of whom derive only a small fraction of their business from these sales while providing a substantial benefit to the community, to complete such an expensive, time-consuming accreditation process every three years in order to stay in this market.”
Former Lansinoh CEO shifts to Insight Pharmaceuticals
LANGHORNE, Pa. A developer, manufacturer and marketer of OTC consumer brands has appointed a new chief executive.
Insight Pharmaceuticals, maker of such brands as Anacin and Dermarest, announced that Gary Downing will become CEO of the company Feb. 15. Prior to this appointment, Downing served as CEO of breastfeeding product maker Lansinoh for nearly eight years, leading the company’s and profitability to grow more than fivefold and sevenfold, respectively. Downing also co-founded niche OTC brand marketing company Medtech, and held senior management positions at such industry leaders as Rhone-Poulene Rorer, Gillette’s Oral-B Labs and Richardson-Vicks, where he had a successful track record of developing profitable businesses.
“We are very excited to have someone of Gary’s caliber joining the Insight team and are looking forward to his leadership and contribution to further the growth of our business. His background and experience in acquiring and developing brands are a perfect complement to our long-term strategy,” said Mo Stout, Insight Pharmaceuticals chairman.